Zimmer Biomet Holdings (ZBH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 705,100 | 905,200 | 1,025,100 | 291,200 | 445,500 |
| Depreciation Amortization | 1,093,800 | 996,300 | 951,700 | 1,219,200 | 954,000 |
| Income taxes - deferred | -87,200 | -47,700 | -96,300 | -64,400 | -102,100 |
| Accounts receivable | -127,300 | -89,700 | -51,900 | -184,700 | -40,800 |
| Other Working Capital | -104,900 | -455,400 | -398,700 | -311,400 | -134,200 |
| Other Operating Activity | 217,600 | 190,700 | 151,700 | 406,300 | 281,900 |
| Operating Cash Flow | $1,697,100 | $1,499,400 | $1,581,600 | $1,356,200 | $1,404,300 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -525,000 | -444,100 | -602,800 | -446,200 | -417,200 |
| Net Acquisitions | -1,393,200 | -276,300 | -134,900 | -99,800 | N/A |
| Purchase Sale Intangibles | -52,400 | -153,000 | -103,400 | -29,700 | -8,400 |
| Other Investing Activity | -57,500 | -167,700 | -41,200 | 24,000 | -26,100 |
| Investing Cash Flow | $-1,975,700 | $-888,100 | $-778,900 | $-522,000 | $-443,300 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,492,100 | 1,436,300 | 499,800 | 83,000 | 1,599,800 |
| Debt Repayment | -1,463,000 | -900,000 | -445,200 | -1,143,700 | -2,654,800 |
| Common Stock Issued | 39,700 | 82,100 | 101,100 | 78,100 | 122,500 |
| Common Stock Repurchased | -487,000 | -868,000 | -692,200 | -126,400 | N/A |
| Dividend Paid | -190,300 | -196,000 | -200,900 | -201,200 | -200,100 |
| Other Financing Activity | -65,500 | -38,900 | -26,100 | 534,500 | -173,400 |
| Financing Cash Flow | $326,000 | $-484,500 | $-763,500 | $-775,700 | $-1,306,000 |
| Exchange Rate Effect | 19,000 | -17,100 | 900 | -14,500 | -13,200 |
| Beginning Cash Position | 525,500 | 415,800 | 375,700 | 478,500 | 802,100 |
| End Cash Position | 591,900 | 525,500 | 415,800 | 375,700 | 478,500 |
| Net Cash Flow | $66,400 | $109,700 | $40,100 | $-102,800 | $-323,600 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,697,100 | 1,499,400 | 1,581,600 | 1,356,200 | 1,404,300 |
| Capital Expenditure | -525,000 | -444,100 | -602,800 | -446,200 | -417,200 |
| Free Cash Flow | 1,172,100 | 1,055,300 | 978,800 | 910,000 | 987,100 |